SEC Form 4 · accession 0001587221-17-000007
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winnie Wing-Kei Tso
Officer — Chief Financial Officer
Period of report
Apr 10, 2017
Accepted (ET)
Apr 12, 2017 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.57 | Apr 10, 2017 | A | 3,500 | A | Apr 10, 2017 | Mar 29, 2026 | Common Stock | 3,500 | 17,500 | D |
Explanation of responses
- F1Effective March 29, 2016, the reporting person was granted an option to purchase 17,500 shares of common stock. The option vests according to the following schedule: 80% vested upon the achievement of one performance milestone, which occurred on June 30, 2016, and 20% vests upon the achievement of a second performance milestone (the "Second Milestone"). The Second Milestone occurred on April 10, 2017, resulting in vesting of the option as to 3,500 shares.